Fig. 4. Rb loss is one possible mechanism of resistance to JQ1 + palbociclib.
a Frequency of RB1 E864* mutation detected by ddPCR in pre-treatment cell populations and after selection with JQ1, palbociclib, and paclitaxel, alone and in combinations. Source data are provided as a Source Data file. b Western blots show pRB levels in wild-type and RB1-deleted SUM159 cells. c Levels of synergism between JQ1 and palbociclib in wild-type and RB1-deleted cells at various doses. Each point represents the combination index (CI) for one pair of concentrations, averaged over eight replicates. CI = 1 additive, CI < 1 synergistic, and CI > 1 antagonistic. Source data are provided as a Source Data file. d Growth curves of wild-type and RB1-deleted cells treated with DMSO or 77 nM JQ1 + 611 nM palbociclib. Data are represented as mean ± SD, n = 68 for DMSO and n = 8 for JQ1 + palbociclib, one-way ANOVA followed by Sidak’s multiple comparisons test. Source data are provided as a Source Data file.